Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,361 | 6,457 | 7,471 | 8,270 | 7,091 |
| Receivables | 627 | 43 | 50 | 126 | 1,256 |
| TOTAL | $6,437 | $6,914 | $8,130 | $9,087 | $9,092 |
| Non-Current Assets | |||||
| PPE Net | 9 | 10 | 11 | 12 | 13 |
| Intangibles | 2,180 | 2,205 | 2,231 | 2,256 | 2,281 |
| Other Non-Current Assets | 265 | 290 | 303 | 320 | 190 |
| TOTAL | $2,454 | $2,505 | $2,544 | $2,588 | $2,484 |
| Total Assets | $8,890 | $9,420 | $10,674 | $11,675 | $11,576 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,747 | 1,454 | 1,499 | 1,211 | 2,122 |
| TOTAL | $1,822 | $1,529 | $1,565 | $1,280 | $2,141 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 20 | 40 | 109 | 121 | 44 |
| TOTAL | $20 | $40 | $109 | $121 | $44 |
| Total Liabilities | $1,842 | $1,569 | $1,674 | $1,401 | $2,184 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,165 | 3,014 | 2,942 | 2,866 | 2,766 |
| Common Shares | 46,643 | 46,141 | 45,454 | 44,474 | 42,473 |
| Retained earnings | -52,419 | -50,699 | -48,714 | -46,379 | -44,045 |
| Other shareholders' equity | -215 | -190 | -230 | -239 | -214 |
| TOTAL | $7,049 | $7,851 | $9,000 | $10,274 | $9,391 |
| Total Liabilities And Equity | $8,890 | $9,420 | $10,673 | $11,675 | $11,576 |